EXETF (Extendicare) Other Operating Expense: $123 Mil (TTM As of Mar. 2026)


EXETF Extendicare Inc EXETF
76 GF Score
Price $25.78
GF Value $10.01
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Extendicare Other Operating Expense?

Extendicare EXETF +5.14% 76 Other Operating Expense is $123 Mil as of Mar. 2026. GuruFocus rates EXETF with a GF Score™ of 76/100 and a GF Value™ of $10.01 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Extendicare's Other Operating Expense for the three months ended in Mar. 2026 was $32 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $123 Mil.

Extendicare's quarterly Other Operating Expense increased from Sep. 2025 ($31 Mil) to Dec. 2025 ($35 Mil) but then declined from Dec. 2025 ($35 Mil) to Mar. 2026 ($32 Mil).

Extendicare's annual Other Operating Expense declined from Dec. 2023 ($116 Mil) to Dec. 2024 ($110 Mil) but then increased from Dec. 2024 ($110 Mil) to Dec. 2025 ($119 Mil).

Extendicare Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Extendicare's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Extendicare Other Operating Expense Chart

Extendicare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 123.13 117.34 116.39 110.13 118.78

Extendicare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.14 25.44 31.02 35.27 31.54
EXETF
76GF Score
Extendicare Inc EXETF
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Extendicare Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $123 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $123 Mil mean?
Extendicare (EXETF) has a Other Operating Expense of $123 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Extendicare and its competitors.
Is Extendicare's Other Operating Expense too high?
Extendicare's current Other Operating Expense is $123 Mil. Overall, Extendicare has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Extendicare's Other Operating Expense compare to HCA and THC?
Extendicare's Other Operating Expense of $123 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Healthcare Providers & Services company?
A good Other Operating Expense depends on the Healthcare Providers & Services industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Extendicare and its competitors. Extendicare's current Other Operating Expense is $123 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Extendicare stock overvalued right now?
Based on GuruFocus' analysis, Extendicare (EXETF) is currently considered Significantly Overvalued. The stock's GF Value™ is $10.01, compared to a current price of $25.78 — trading 157.5% above its estimated fair value. The current Other Operating Expense is $123 Mil. Extendicare's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Extendicare (EXETF), the current Other Operating Expense is $123 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Extendicare (EXETF) Overvalued in 2026?

Based on GuruFocus' analysis, Extendicare stock appears to be overvalued. The current stock price of $25.78 is trading 157.5% above its estimated GF Value™ of $10.01. GuruFocus considers Extendicare to be Significantly Overvalued.

Key valuation signals for EXETF:

  • Other Operating Expense: $123 Mil
  • GF Value™: $10.01 vs. price of $25.78 (157.5% above fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the EXETF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Extendicare Business Description

Address 3000 Steeles Avenue East, Suite 400, Markham, ON, CAN, L3R 4T9
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The has three main business segments: Long-term Care (LTC), Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada. The majority of the company's revenue is derived from the Long-term Care segment.
76GF Score

Get the complete analysis for EXETF

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.78
Price
$10.01
GF Value